A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin
暂无分享,去创建一个
[1] Tucker Bw,et al. Hypoglycemic actions of tolbutamide and carbutamide. , 1956 .
[2] I. Mirsky,et al. The inhibition of insulinase by hypoglycemic sulfonamides. , 1956, Metabolism: clinical and experimental.
[3] Auguste Loubatières. THE HYPOGLYCEMIC SULFONAMIDES: HISTORY AND DEVELOPMENT OF THE PROBLEM FROM 1942 TO 1955 , 1957, Annals of the New York Academy of Sciences.
[4] L. Stimmler. Immunoassay of insulin with insulin antibody precipitate. , 1963, Lancet.
[5] G. Reaven,et al. Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.
[6] D. Steiner,et al. Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.
[7] D. Steiner,et al. The metabolism of proinsulin and insulin by the liver. , 1972, The Journal of clinical investigation.
[8] S. Genuth. Metabolic Clearance of Insulin in Man , 1972, Diabetes.
[9] W. Duckworth,et al. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. , 1972, The Journal of clinical endocrinology and metabolism.
[10] P. Sönksen,et al. A comparative study on the metabolism of human insulin and porcine proinsulin in man. , 1973, Clinical science and molecular medicine.
[11] J. Field. Extraction of insulin by liver. , 1973, Annual review of medicine.
[12] D. Steiner,et al. Binding and degradation of 125I-insulin by rat hepatocytes. , 1975, The Journal of biological chemistry.
[13] E. Tsalikian,et al. The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal , 1977, Diabetes.
[14] E. Ferrannini,et al. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. , 1978, The Journal of clinical investigation.
[15] H. Lebovitz,et al. Sulphonylureas increase the number of insulin receptors , 1978, Nature.
[16] E. Cerasi,et al. Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. , 1979, Acta endocrinologica.
[17] R. DeFronzo,et al. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. , 1983, The American journal of physiology.
[18] R. Eaton,et al. Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. , 1983, The Journal of clinical endocrinology and metabolism.
[19] R. Eaton,et al. Insulin removal in man: in vivo evidence for a receptor-mediated process. , 1984, The Journal of clinical endocrinology and metabolism.
[20] R. DeFronzo,et al. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. , 1984, Diabetes.
[21] R. DeFronzo,et al. Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy , 1984, Diabetes.
[22] K. Polonsky,et al. C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations , 1984, Diabetes.
[23] J. Olefsky,et al. Retroendocytosis of insulin in rat adipocytes. , 1986, Endocrinology.
[24] N. Barzilai,et al. Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients. , 1986, Metabolism: clinical and experimental.
[25] A. Zeidler,et al. Glyburide and Glipizide in Treatment of Diabetic Patients With Secondary Failures to Tolazamide or Chlorpropamid , 1987, Diabetes Care.
[26] L. Groop,et al. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. , 1987, Diabetes care.
[27] L. Groop,et al. Do Sulfonylureas Influence Hepatic Insulin Clearance? , 1988, Diabetes Care.
[28] K. Polonsky,et al. Reduction of Insulin Clearance During Hyperglycemic Clamp: Dose-Response Study in Normal Humans , 1988, Diabetes.
[29] A. Scheen,et al. Decreased or Increased Insulin Metabolism After Glipizide in Type II Diabetes? , 1988, Diabetes Care.
[30] J. Clore,et al. Reduced Insulin Clearance in Normal Subjects Due To Extreme Hyperinsulinemia , 1988, The American journal of the medical sciences.
[31] H. Galbo,et al. Postexercise dose-response relationship between plasma glucose and insulin secretion. , 1988, Journal of applied physiology.
[32] L. Groop,et al. Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM , 1992, Diabetes Care.
[33] L. Groop. Sulfonylureas in NIDDM , 1992, Diabetes Care.
[34] J. Halter,et al. The regulation of glucose-induced insulin secretion by Pre-stimulus glucose level and tolbutamide in normal man , 1981, Diabetologia.
[35] A. Pontiroli,et al. Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM) , 2004, European Journal of Clinical Pharmacology.
[36] A. Scheen,et al. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients , 2004, European Journal of Clinical Pharmacology.
[37] A. Melander,et al. Influence of sulfonylureas on the secretion, disposal and effect of insulin , 2004, European Journal of Clinical Pharmacology.
[38] L. Groop,et al. Therapeutic equivalence of once- and thrice-daily glipizide , 2004, European Journal of Clinical Pharmacology.
[39] L. Heding. Radioimmunological determination of human C-peptide in serum , 1975, Diabetologia.